17 June 2025 in Cancer Treatment and Research Communications
Through comprehensive analysis of cisplatin-resistant HeLa cervical cancer cells, we reveal that curcumin exerts potent anti-cancer effects by modulating autophagic processes, and further identify Endoplasmic reticulum oxidoreductase 1-alpha (ERO1α) as a key regulator mediating this biological response. Cell proliferation was assessed using Cell Counting Kit-8 (CCK-8). The immunoblotting analysis measured the Phosphoinositide 3-Kinase/ Protein Kinase B (PI3K/AKT) pathway-related proteins, Microtubule-associated protein 1A/1B-light chain 3 (LC3II/I) ratio, and Beclin-1 expression. The cell migration ability was evaluated through a scratch assay. Curcumin significantly inhibits the proliferation and migration of cisplatin-resistant HeLa cells. It promotes autophagy in these cells, as shown by the upregulation of autophagy-related proteins Beclin-1 and LC3II/I. Curcumin also downregulates ERO1α expression, subsequently modulating the PI3K/AKT pathway. Interestingly, the overexpression of ERO1α or activation of PI3K negated the autophagy-promoting effects of curcumin, indicated by the absence of changes in autophagy-related proteins and phosphorylation levels of PI3K/AKT. Our study provides compelling evidence that curcumin inhibits the proliferation and migration of cisplatin-resistant HeLa cells by promoting autophagy through the downregulation of ERO1α and inhibition of the PI3K/AKT pathway.
30 July 2026 in International Journal of Gastrointestinal Intervention
Yumchinserchin Narangerel, Tsendjav Tsogtbaatar, Gonchigsuren Dagvasumberel, Dashkhorol Davaadorj, Enebish Sundui and Adilsaikhan Mendjargal. Int J Gastrointest Interv -0001;0:. https://doi.org/10.18528/ijgii260007
2 August 2025 in Health Leadership and Quality of Life
Objective: This study aimed to investigate the role of Curcumin in modulating miR-582-5p expression in cisplatin (DDP)-resistant cervical cancer cells.Methods: miR-582-5p expression levels were quantified by qPCR. Cell viability following DDP treatment was assessed using the CCK-8 assay. Colony formation ability was evaluated, and the expression of autophagy-related proteins (ATG7, Beclin-1, LC3-II/I) as well as the phosphorylation status of Akt and mTOR were analyzed by Western blotting.Results: miR-582-5p expression was downregulated in DDP-resistant tissues and in Hela/DDP and SiHa/DDP cells. Curcumin treatment reduced the IC50 values of both cell lines and suppressed colony formation. Curcumin upregulated ATG7, Beclin-1, and LC3-II/I expression in DDP-resistant Hela and SiHa cells, while concurrently inhibiting the phosphorylation of Akt and mTOR. miR-582-5p modulated Akt phosphorylation and influenced Curcumin-induced autophagy in these resistant cell lines. Additionally, the phosphorylation status of Akt affected the autophagic response to Curcumin.Conclusions: Curcumin enhances autophagy in DDP-resistant cervical cancer cells, accompanied by downregulation of miR-582-5p and inhibition of Akt/mTOR phosphorylation.
21 April 2026 in Current Traditional Medicine
Introduction: The objective is to examine how curcumin influences cell proliferation and autophagy in cisplatin-resistant cervical cancer cell lines, HeLa and SiHa, by modulating the phosphorylation of the AKT/mTOR signaling pathway. Methods: Cisplatin-resistant cervical cancer cell lines, HeLa/DDP and SiHa/DDP, were established via the concentration escalation method, which was subsequently validated for its resistance phenotype through functional assays, including inhibitory coefficient (IC)50 and resistance index (RI) determination. Cisplatin-resistant cervical cancer cells were stimulated with or without curcumin at 8.5 μM. After 48 hours of treatment, cell proliferation was evaluated by the CCK-8 assay, and immunoblotting was used to detect autophagy-related proteins, LC3II/I, and Beclin-1; in addition, the phosphorylations of AKT and mTOR proteins were evaluated. Results: The IC50 values for cisplatin-resistant cells were 39.34 ng/mL and 37.12 ng/mL of HeLa and SiHa, whereas in the control group of cells, the IC50 values were 7.29 ng/mL and 6.73 ng/mL of HeLa and SiHa. The resistance indices (RIs) of HeLa and SiHa were 5.4 and 5.52, respectively. In relation to the control group, the curcumin significantly reduced cell proliferation rates, reduced phosphorylation of Akt and mTOR, and increased expression of LC3II/I as well as Beclin-1 (P<0.05). In contrast, activation of mTOR by MHY1485 significantly restored the proliferation of both cell lines and reduced the expression of autophagy-related proteins (all P < 0.01). Discussion: This research demonstrated that curcumin suppressed the growth of drug-resistant cervical cancer cells and enhanced autophagy by reducing the phosphorylation of the AKT/mTOR signaling pathway, offering a novel avenue for overcoming drug resistance. Conclusion: Curcumin promotes autophagy and inhibits proliferation in cisplatin-resistant cervical cancer HeLa and SiHa cells by regulating phosphorylation of the AKT/mTOR signaling pathway.